Gastrointestinal

Eversana, Evoke Pharma partner on nasal drug for patients with diabetic gastroparesis

10-Nov-2020 By Jenni Spinner

The two companies have joined forces to collaborate on the commercial launch of Gimoti, a nasal spray for patients suffering from diabetic gastroparesis.

ObjectiveGI, ARcare joining on clinical care options

24-Sep-2020 By Jenni Spinner

The research platform provider will work with the healthcare system to provide GI patients broader diagnostics and treatment.

American Gastroenterological Association opts for virtual trial kit

11-Aug-2020 By Jenni Spinner

The medical organization has selected Rx.Health's TrialEngage, a set of digital tools geared toward supporting and improving decentralized trials.

IBS treatment market growing at CAGR of 10% to 2026

02-Aug-2019 By Ben Hargreaves

The IBS treatment market will develop to be worth $3.3bn by 2026, driven by increased uptake of small molecule treatments and growing incidence.

Spotlight

(Luis Alvarez/iStock via Getty Images Plus)

PharmSci 360 invites industry pros to ‘rethink and evolve’

COVID-19 lessons can apply to hepatitis treatments: Phesi

(John M Lund Photography Inc/iStock via Getty Images Plus)

UCI, Syntropy join forces on research/care data project

Survey seeks to chart adoption of decentralized trials, future plans

Digital revolution transforming drug development: West Pharma

Products

Webinars

Upcoming editorial webinars

17 Nov 2021 Wed Webinar Patient-centric Solutions

On-demand webinars

Featured Suppliers

All suppliers

ACG

Advarra

Ajinomoto Bio-Pharma Services

Baxter BioPharma Solutions

BioContinuum™ Platform - MilliporeSigma

Clinical Ink

Covance Patient Safety

Curia

EVERSANA

Frontage Laboratories

Piramal Pharma Solutions

PRA Health Sciences

Precision for Medicine

Q² Solutions

Signant Health

Softigel by Procaps

Vetter Pharma International GmbH

World Courier

Gastrointestinal

Eversana, Evoke Pharma partner on nasal drug for patients with diabetic gastroparesis

ObjectiveGI, ARcare joining on clinical care options

American Gastroenterological Association opts for virtual trial kit

IBS treatment market growing at CAGR of 10% to 2026

Spotlight

Follow us

Products

Webinars

Featured Suppliers

Free newsletter sign up

Outsourcing-Pharma

Resources